Germany is carrying out Europe’s first large-scale COVID-19 antibody testing to help prevent the spread of the virus and to monitor infection rates.
According to the Robert Koch Institute, Germany’s federal disease control and prevention agency, the study will have three phases. The first phase is to draw on the country’s blood donation services.
The second phase will focus on samples from regions with large COVID-19 outbreaks, and the third phase will consist of a representative study of the country’s wider population.
The Koch Institute said authorities hope to examine 5000 blood samples every 14 days. The antibody test-launched last week, with the initial results to arrive in May.
Articles you might like: COVID-19 Updates: Africa Germany Is Conducting Nationwide COVID-19 Antibody Testing
Germany, which creates most of its high-quality kits, is testing for COVID-19 on a wider scale than other countries.
An estimated amount of 120 000 tests a day in a country of 83 million has helped Germany prevent the spread of the virus and keep the country’s mortality death low.
Officials estimate that the country experiences more recoveries now than deaths.